Marpai 5/9/2024 Earnings Report

Marpai EPS Results

• Actual EPS: -$0.46
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Marpai Revenue Results

• Actual Revenue: $7.39 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Marpai Announcement Details

• Date: 5/9/2024
• Time: After Market Closes
• Conference Call Date: N/A
• Conference Call Time: N/A

Marpai (NASDAQ:MRAI) Inc. is a technology-driven healthcare benefits management company that leverages data analytics and artificial intelligence to optimize health outcomes and control costs for self-insured employers. Its flagship Marpai Health Platform integrates personalized care pathways, advanced member engagement tools and real-time claims analytics. By combining machine learning models with clinical expertise, Marpai identifies risk patterns early and guides members toward cost-effective, high-quality care.

Marpai’s suite of services encompasses underwriting, care coordination, pharmacy benefits management and virtual health coaching, all delivered through a unified digital interface. The platform offers proactive notifications, personalized recommendations and continuous support to help members navigate complex healthcare decisions. Employers using Marpai’s solutions gain greater visibility into cost drivers and can realize measurable reductions in total medical expenses.

Founded by a team of healthcare and technology professionals, Marpai is headquartered in the United States and primarily serves mid-sized to large self-insured organizations across diverse industries. The company’s data-driven approach underpins sustainable cost management and enhances member satisfaction through transparent pricing, targeted interventions and evidence-based care pathways.

Marpai began trading on the NASDAQ under the symbol MRAI, marking its transition to a public company committed to advancing innovation in digital health. While focused on the U.S. market, Marpai continues to explore strategic partnerships and product enhancements designed to expand its capabilities and refine its precision health insights.